Literature DB >> 16206278

Antibody variable region interactions with Protein A: implications for the development of generic purification processes.

Sanchayita Ghose1, Martin Allen, Brian Hubbard, Clayton Brooks, Steven M Cramer.   

Abstract

In this paper, a wide range of antibodies from various subclasses and subfamilies are employed to evaluate the creation of generic separation processes using Protein A chromatography. The reasons for elution pH differences amongst several IgG1s, IgG2s, antibody fragments, and Fc-fusion proteins during Protein A chromatography are investigated using several complimentary techniques. The results indicate that variable region interactions play a major role in determining elution pH for VH3 subfamily antibodies while using traditional protein A chromatographic materials. On the other hand, experiments with a resin which employs a ligand consisting solely of B domain of Protein A indicate that variable region interactions can be mitigated, enabling the use of a single elution pH for a range of antibodies. Finally, the moderation of elution conditions associated with this engineered ligand are shown to minimize problems associated with low pH induced aggregation. It is expected that the findings reported in this paper will facilitate faster process development cycle times for this important class of human therapeutics. (c) 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16206278     DOI: 10.1002/bit.20729

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  20 in total

Review 1.  Recovery and purification process development for monoclonal antibody production.

Authors:  Hui F Liu; Junfen Ma; Charles Winter; Robert Bayer
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

2.  Crystallization and preliminary X-ray diffraction studies of an RNA aptamer in complex with the human IgG Fc fragment.

Authors:  Shigeru Sugiyama; Yusuke Nomura; Taiichi Sakamoto; Tomoya Kitatani; Asako Kobayashi; Shin Miyakawa; Yoshinori Takahashi; Hiroaki Adachi; Kazufumi Takano; Satoshi Murakami; Tsuyoshi Inoue; Yusuke Mori; Yoshikazu Nakamura; Hiroyoshi Matsumura
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-09-30

3.  Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G.

Authors:  Shin Miyakawa; Yusuke Nomura; Taiichi Sakamoto; Yoshiki Yamaguchi; Koichi Kato; Satoko Yamazaki; Yoshikazu Nakamura
Journal:  RNA       Date:  2008-04-25       Impact factor: 4.942

4.  Improved Protein-A separation of V(H)3 Fab from Fc after papain digestion of antibodies.

Authors:  Therese A Seldon; Karen E Hughes; David J Munster; David Y Chin; Martina L Jones
Journal:  J Biomol Tech       Date:  2011-07

5.  Immobilization of Bioactive Protein A from Staphylococcus aureus (SpA) on the Surface of Bacillus subtilis Spores.

Authors:  Samira Ghaedmohammadi; Garshasb Rigi; Reza Zadmard; Ezio Ricca; Gholamreza Ahmadian
Journal:  Mol Biotechnol       Date:  2015-08       Impact factor: 2.695

6.  Investigating the interaction between the neonatal Fc receptor and monoclonal antibody variants by hydrogen/deuterium exchange mass spectrometry.

Authors:  Pernille Foged Jensen; Vincent Larraillet; Tilman Schlothauer; Hubert Kettenberger; Maximiliane Hilger; Kasper D Rand
Journal:  Mol Cell Proteomics       Date:  2014-11-06       Impact factor: 5.911

7.  Reverse calcium affinity purification of Fab with calcium derivatized hydroxyapatite.

Authors:  Pete Gagnon; Chia-Wei Cheung; Paul J Yazaki
Journal:  J Immunol Methods       Date:  2009-01-14       Impact factor: 2.303

Review 8.  RNA plasticity and selectivity applicable to therapeutics and novel biosensor development.

Authors:  Yoshikazu Nakamura; Akira Ishiguro; Shin Miyakawa
Journal:  Genes Cells       Date:  2012-04-04       Impact factor: 1.891

9.  Conformational plasticity of RNA for target recognition as revealed by the 2.15 A crystal structure of a human IgG-aptamer complex.

Authors:  Yusuke Nomura; Shigeru Sugiyama; Taiichi Sakamoto; Shin Miyakawa; Hiroaki Adachi; Kazufumi Takano; Satoshi Murakami; Tsuyoshi Inoue; Yusuke Mori; Yoshikazu Nakamura; Hiroyoshi Matsumura
Journal:  Nucleic Acids Res       Date:  2010-07-30       Impact factor: 16.971

10.  A protein A based Staphylococcus aureus vaccine with improved safety.

Authors:  Miaomiao Shi; Xinhai Chen; Yan Sun; Hwan Keun Kim; Olaf Schneewind; Dominique Missiakas
Journal:  Vaccine       Date:  2021-06-01       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.